A significant recall of antidepressants was prompted by a patient discovering the wrong medication in their pack on April 29, 2026, in the UK. Over 80,000 packs of Sertraline have been recalled due to incorrect packaging.
The issue surfaced when a patient found Citalopram tablets inside a pack meant for Sertraline—both are SSRIs used to treat depression and anxiety. This alarming medication error occurred during the secondary packaging of the blister strips into cartons.
Amarox Limited initiated the recall as a precautionary measure, emphasizing patient safety. The affected batch number is V2500425, which comprises a total batch size of 81,872 packs.
Dr. Alison Cave from the Medicines and Healthcare products Regulatory Agency (MHRA) stated, “If you have been prescribed Sertraline 100mg tablets and have received batch number V2500425, please check the carton contains the right medication.” This advice is critical for those who may be affected.
Patients who mistakenly took Citalopram should seek medical advice immediately. Dr. Cave warned that these patients may experience heightened serotonergic side effects, which can include nausea, headache, sleep changes, and mild anxiety.
This incident not only highlights the importance of accurate pharmaceutical practices but also raises questions about how such errors can impact mental health treatment. In 2019 alone, over 16.7 million prescriptions of Sertraline were issued by GPs in England.
The MHRA’s swift response underscores the need for vigilance in ensuring medication safety—especially for those relying on SSRIs for their mental health needs. As this situation unfolds, it remains essential for patients to stay informed and proactive regarding their prescriptions.